http://orcid.org/0000-0003-4895-9707
Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Alfredo Chetta & Paola Rogliani. (2022) Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies. Expert Review of Respiratory Medicine 16:3, pages 357-365.
Read now
Read now
Liu-Cheng Li, Yong-Yue Han, Zhi-Hui Zhang, Wen-Cheng Zhou, Hong-Mei Fang, Jiao Qu & Lian-Di Kan. (2021) Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management. Drug Design, Development and Therapy 15, pages 111-124.
Read now
Read now
Luigino Calzetta, Beatrice Ludovica Ritondo, Patrizia de Marco, Mario Cazzola & Paola Rogliani. (2021) Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies. Expert Review of Respiratory Medicine 15:1, pages 143-152.
Read now
Read now
Paola Rogliani, Beatrice Ludovica Ritondo, Bartolomeo Zerillo, Mario Cazzola, Maria Gabriella Matera & Luigino Calzetta. (2020) Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 215-223.
Read now
Read now
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now
Read now
Luigino Calzetta, Maria Gabriella Matera & Paola Rogliani. (2019) Monoclonal antibodies in severe asthma: is it worth it?. Expert Opinion on Drug Metabolism & Toxicology 15:6, pages 517-520.
Read now
Read now
Peter MA Calverley, Clive Page, Roberto W Dal Negro, Giovanni Fontana, Mario Cazzola, Arrigo F Cicero, Edoardo Pozzi & Jadwiga A Wedzicha. (2019) Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2733-2744.
Read now
Read now
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2018) Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 12:8, pages 693-708.
Read now
Read now
Zaurbek Aisanov, Sergey Avdeev, Vladimir Arkhipov, Andrey Belevskiy, Alexander Chuchalin, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2018) Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 183-187.
Read now
Read now
Mario Cazzola, Paola Rogliani, Ermanno Puxeddu, Josuel Ora & Maria Gabriella Matera. (2018) An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Review of Respiratory Medicine 12:1, pages 43-54.
Read now
Read now
Articles from other publishers (57)
Hao Peng, Qing Zhou, Jing Liu, Yi Wang, Ketao Mu & Lei Zhang. (2023) Endoplasmic reticulum stress: a vital process and potential therapeutic target in chronic obstructive pulmonary disease. Inflammation Research.
Crossref
Crossref
Paula Montero, Inés Roger, Cristina Estornut, Javier Milara & Julio Cortijo. (2023) Influence of dose and exposition time in the effectiveness of N-Acetyl-l-cysteine treatment in A549 human epithelial cells. Heliyon 9:5, pages e15613.
Crossref
Crossref
Mutsuo Yamaya, Akiko Kikuchi, Mitsuru Sugawara & Hidekazu Nishimura. (2023) Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases. Respiratory Investigation 61:2, pages 270-283.
Crossref
Crossref
Chienhsiu Huang, Sufang Kuo, Lichen Lin & Yalun Yang. (2023)
The efficacy of
N
-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis
. Therapeutic Advances in Respiratory Disease 17, pages 175346662311585.
Crossref
Crossref
Paola Rogliani, Josuel Ora, Francesco Cavalli, Mario Cazzola & Luigino Calzetta. (2022) Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score. Journal of Clinical Medicine 11:15, pages 4491.
Crossref
Crossref
Elisabetta Pace, Isa Cerveri, Donato Lacedonia, Gregorino Paone, Alessandro Sanduzzi Zamparelli, Rossella Sorbo, Marcello Allegretti, Luigi Lanata & Francesco Scaglione. (2022) Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action. Pharmaceutics 14:6, pages 1261.
Crossref
Crossref
S. N. Avdeev, N. V. Trushenko, S. Yu. Chikina & O. A. Suvorova. (2022) The potential of erdosteine to reduce the rate of exacerbations of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:2, pages 253-259.
Crossref
Crossref
Ai-Ling Shen, Hsiu-Li Lin, Hsiu-Chen Lin, Jane Chen-Jui Chao, Chien-Yeh Hsu & Chung-Yu Chen. (2022) The effects of medications for treating COPD and allied conditions on stroke: a population-based cohort study. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
Zacharias Fögen. (2022) The Foegen effect. Medicine 101:7, pages e28924.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
247
300
.
Leszek Wojnowski. 2022. Arzneiverordnungs-Report 2022. Arzneiverordnungs-Report 2022
601
609
.
Adrienne S. Murray. (2021) Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease: A Cochrane review summary. International Journal of Nursing Studies 124, pages 103711.
Crossref
Crossref
Paola Rogliani, Richard Beasley, Mario Cazzola & Luigino Calzetta. (2021) SMART for the treatment of asthma: A network meta-analysis of real-world evidence. Respiratory Medicine 188, pages 106611.
Crossref
Crossref
Yi Wang, Li-Fan Hu, Tian-Jiao Zhou, Lian-Yu Qi, Lei Xing, Jaiwoo Lee, Feng-Zhen Wang, Yu-Kyoung Oh & Hu-Lin Jiang. (2021) Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations. Biomaterials 277, pages 121108.
Crossref
Crossref
Paola Rogliani, Beatrice Ludovica Ritondo & Luigino Calzetta. (2021) Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies. European Respiratory Journal 58:3, pages 2004233.
Crossref
Crossref
Micaely Cristina dos Santos Tenório, Nayara Gomes Graciliano, Fabiana Andréa Moura, Alane Cabral Menezes de Oliveira & Marília Oliveira Fonseca Goulart. (2021) N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants 10:6, pages 967.
Crossref
Crossref
Nicolas Roche. (2021) Systemic Medications in Chronic Obstructive Pulmonary Disease. Thoracic Surgery Clinics 31:2, pages 97-106.
Crossref
Crossref
Luigino Calzetta, Beatrice Ludovica Ritondo, Angelo Coppola, Maria Gabriella Matera, Nicola Di Daniele & Paola Rogliani. (2021) Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials. Vaccines 9:4, pages 341.
Crossref
Crossref
Alberto Papi, Sergey Avdeev, Peter M.A. Calverley, Carlos R. Cordeiro, Milos Jesenak, Vladimir Koblížek, Diana Petkova, Paola Rogliani, Hesham Tarraf, Nikolaos Tzanakis, Ruxandra Ulmeanu, Esra Uzaslan & Yochai Adir. (2020) Use of mucolytics in COPD: A Delphi consensus study. Respiratory Medicine 175, pages 106190.
Crossref
Crossref
S. Yu. Chikina. (2020) A role of thiamphenicol glycinate acetylcysteinate for therapy of respiratory diseases (a review). Meditsinskiy sovet = Medical Council:17, pages 109-112.
Crossref
Crossref
Luigino Calzetta, Elena Pistocchini, Beatrice Ludovica Ritondo, Paola Roncada, Ernesto Palma, David di Cave, Maurizio Mattei & Domenico Britti. (2020) Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union. Vaccine 38:43, pages 6695-6703.
Crossref
Crossref
Paola Rogliani, Beatrice Ludovica Ritondo, Josuel Ora, Mario Cazzola & Luigino Calzetta. (2020) SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis. European Respiratory Journal 56:3, pages 2000625.
Crossref
Crossref
Nicolas Roche. (2020) Systemic Medications in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 485-494.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, A. V. Emel'yanov, I. V. Demko, G. L. Ignatova, I. N. Trofimenko & E. I. Shmelev. (2020) Inhalation glucocorticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 30:3, pages 330-343.
Crossref
Crossref
P.S. Shankar, K. Korukonda, S. Bendre, D. Behera, L. Mirchandani, N.T. Awad, R. Prasad, S. Bhargava, O.P. Sharma & S.K. Jindal. (2020) Diagnoses and management of adult cough: An Indian Environmental Medical Association (EMA) position paper. Respiratory Medicine 168, pages 105949.
Crossref
Crossref
Mark Borthwick, Danny McAuley, John Warburton, Rohan Anand, Judy Bradley, Bronwen Connolly, Bronagh Blackwood, Brenda O’Neill, Marc Chikhani, Paul Dark & Murali Shyamsundar. (2020) Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals’ perception, pharmacists’ description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients. PeerJ 8, pages e8828.
Crossref
Crossref
Shi B. Chia, Evan A. Elko, Reem Aboushousha, Allison M. Manuel, Cheryl van de Wetering, Joseph E. Druso, Jos van der Velden, David J. Seward, Vikas Anathy, Charles G. Irvin, Ying-Wai Lam, Albert van der Vliet & Yvonne M. W. Janssen-Heininger. (2020)
Dysregulation of the glutaredoxin/
S-
glutathionylation redox axis in lung diseases
. American Journal of Physiology-Cell Physiology 318:2, pages C304-C327.
Crossref
Crossref
Luigino Calzetta, Elena Pistocchini, Antonio Leo, Paola Roncada, Beatrice Ludovica Ritondo, Ernesto Palma, David di Cave & Domenico Britti. (2020) Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations. Heliyon 6:2, pages e03256.
Crossref
Crossref
Nina Kuzmenko, Oleg Iaremenko, Dmytro Dobrianskiy, Roman Ilnytskyi & Galyna Gumeniuk. (2020) The efficacy and safety of inhaled acetylcysteine in comparison with oral acetylcysteine in chronic obstructive pulmonary disease: A randomized single-center study. Polish Annals of Medicine.
Crossref
Crossref
Anuradha Ratna, Shyamali Mukherjee & Salil K. Das. 2020. Oxidative Stress in Lung Diseases. Oxidative Stress in Lung Diseases
177
211
.
A. Zanasi, M. Mazzolini & U. Caliceti. 2020. Cough: Pathophysiology, Diagnosis and Treatment. Cough: Pathophysiology, Diagnosis and Treatment
157
173
.
Paola Rogliani, Luigino Calzetta, Josuel Ora, Mario Cazzola & Maria Gabriella Matera. (2019) Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis. Multidisciplinary Respiratory Medicine 14:1.
Crossref
Crossref
Paola Rogliani, Maria Gabriella Matera, Clive Page, Ermanno Puxeddu, Mario Cazzola & Luigino Calzetta. (2019) Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory Research 20:1.
Crossref
Crossref
Luigino Calzetta, Fabiano Di Marco, Francesco Blasi, Mario Cazzola, Stefano Centanni, Claudio Micheletto, Andrea Rossi & Paola Rogliani. (2019) Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis. Pulmonary Pharmacology & Therapeutics 59, pages 101855.
Crossref
Crossref
Paola Rogliani, Maria Gabriella Matera, Beatrice Ludovica Ritondo, Ilaria De Guido, Ermanno Puxeddu, Mario Cazzola & Luigino Calzetta. (2019) Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations. Pulmonary Pharmacology & Therapeutics 59, pages 101841.
Crossref
Crossref
Zeng Dewen & Liao Suqun. (2019) Efficacy of N-acetyl-L-cysteine and Budesonide/Formoterol Combination for the Treatment of Patients with BCO from China. Efficacy of N-acetyl-L-cysteine and Budesonide/Formoterol Combination for the Treatment of Patients with BCO from China.
Begum Ergan, Simon Oczkowski, Bram Rochwerg, Annalisa Carlucci, Michelle Chatwin, Enrico Clini, Mark Elliott, Jesus Gonzalez-Bermejo, Nicholas Hart, Manel Lujan, Jacek Nasilowski, Stefano Nava, Jean Louis Pepin, Lara Pisani, Jan Hendrik Storre, Peter Wijkstra, Thomy Tonia, Jeanette Boyd, Raffaele Scala & Wolfram Windisch. (2019) European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. European Respiratory Journal 54:3, pages 1901003.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Clive Page, Paola Rogliani & Maria Gabriella Matera. (2019) Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics. Trends in Pharmacological Sciences 40:7, pages 452-463.
Crossref
Crossref
Paola Rogliani, Maria Gabriella Matera, Luigino Calzetta, Nicola A. Hanania, Clive Page, Immacolata Rossi, Aikaterini Andreadi, Angelica Galli, Angelo Coppola, Mario Cazzola & Davide Lauro. (2019) Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients. Respiratory Medicine 154, pages 86-92.
Crossref
Crossref
Paola Rogliani & Luigino Calzetta. (2019) Critical interpretation of pairwise and network meta-analysis of randomized respiratory clinical trials. AboutOpen 5:1, pages 55-61.
Crossref
Crossref
S Moitra. (2019) N-acetylcysteine (NAC) in COPD: benefits often lost in trials. QJM: An International Journal of Medicine 112:5, pages 387-388.
Crossref
Crossref
Luigino Calzetta, Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2019) Adding a LAMA to ICS/LABA Therapy. Chest 155:4, pages 758-770.
Crossref
Crossref
I. M. Melnikova & Yu. L. Minernitsky. (2019) Individually orientated choice of mucolytic drug for coughing in a child with acute respiratory viral infections. Medical Council:2, pages 224-230.
Crossref
Crossref
Juan Carlos Vázquez-García, Rafael de Jesús Hernández-Zenteno, José Rogelio Pérez-Padilla, María del Carmen Cano-Salas, Margarita Fernández-Vega, Jorge Salas-Hernández, Marco Antonio Figueroa-Morales, Rosaura Esperanza Benítez-Pérez, Luis Adrián Rendón-Pérez, Jesús Vázquez-Cortés, Mayra Edith Mejía-Ávila, José Luis Mayorga-Butrón, Moisés Acuña-Kaldman, Rocío Barriga-Acevedo, Alma Rosa Bizarrón-Muro, Robert Camargo-Ángeles, Catalina Casillas-Suárez, Celia Oralia Castañeda-Hernández, Rafael Patricio Castañón-Rodríguez, Juan Francisco Castillo-Sánchez, Arturo Cortés-Télles, Jesús Javier Díaz-Castañón, Abelardo Elizondo Ríos, María Guadalupe Espitia-Hernández, Martha Angélica García-Avilés, Rogelio García-Torrentera, Julio Edgardo González Aguirre, Fernando Carlos Guillén-Ortega, José Carlos Herrera-García, Marco Antonio Loustaunau-Andrade, Gerardo Ezequiel Magdaleno Maldonado, Luz Audina Mendoza Topete, José Padua-García, Andrés Palomar-Lever, Rafael Francisco Páramo-Arroyo, Saraí del Carmen Toral-Freyre, José Felipe Villegas-Elizondo & Edgar Gerardo Zozoaga-Velázquez. (2019) Guía de Práctica Clínica Mexicana para el diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica <br>GUÍA MEXICANA DE EPOC, 2020. NCT Neumología y Cirugía de Tórax 78:S1, pages 4-76.
Crossref
Crossref
Hana Kotolová & Tomáš Hammer. (2018) Chronic obstructive pulmonary disease. Praktické lékárenství 14:4, pages 156-160.
Crossref
Crossref
Vincent Su, Diahn-Warng Perng, Ting-Chun Chou, Yueh-Ching Chou, Yuh-Lih Chang, Chia-Chen Hsu, Chia-Lin Chou, Hsin-Chen Lee, Tzeng-Ji Chen & Po-Wei Hu. (2018) Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap. Journal of Clinical Medicine 7:12, pages 517.
Crossref
Crossref
Mario Cazzola, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2018)
Triple therapy
versus
single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
. European Respiratory Journal 52:6, pages 1801586.
Crossref
Crossref
Umit M. Sahiner, Esra Birben, Serpil Erzurum, Cansin Sackesen & Ömer Kalayci. (2018) Oxidative stress in asthma: Part of the puzzle. Pediatric Allergy and Immunology 29:8, pages 789-800.
Crossref
Crossref
Roberto Dal Negro, Edoardo Pozzi & Silvano G. Cella. (2018) Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases. Pulmonary Pharmacology & Therapeutics 53, pages 80-85.
Crossref
Crossref
Cong Liu, Yana Ma, Zhenlei Su, Runzhen Zhao, Xiaoli Zhao, Hong-Guang Nie, Ping Xu, Lili Zhu, Mo Zhang, Xiumin Li, Xiaoju Zhang, Michael A. Matthay & Hong-Long Ji. (2018) Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury. Frontiers in Immunology 9.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani, Clive Page & Maria Gabriella Matera. (2018) Impact of doxofylline in COPD: A pairwise meta-analysis. Pulmonary Pharmacology & Therapeutics 51, pages 1-9.
Crossref
Crossref
Luigino Calzetta, Paola Rogliani, Francesco Facciolo, Barbara Rinaldi, Mario Cazzola & Maria Gabriella Matera. (2018) N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. Biomedicine & Pharmacotherapy 103, pages 1-8.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Peter J. Barnes, Gerard J. Criner, Fernando J. Martinez, Alberto Papi & Maria Gabriella Matera. (2018) Efficacy and safety profile of xanthines in COPD: a network meta-analysis. European Respiratory Review 27:148, pages 180010.
Crossref
Crossref
Janis K Shute, Ermanno Puxeddu & Luigino Calzetta. (2018) Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD. Current Opinion in Pharmacology 40, pages 39-45.
Crossref
Crossref
Neil C Thomson. (2018) Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities. Current Opinion in Pharmacology 40, pages 1-8.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Clive Page, Paola Rogliani & Maria Gabriella Matera. (2018) Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. Pulmonary Pharmacology & Therapeutics 48, pages 185-194.
Crossref
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
203
252
.